News & Events
All News
-
Social Impact Nonprofit Roivant Social Ventures Announces Leadership Team, Inaugural Partnership, and Publication in Nature Gene Therapy
August 17, 2021 -
LabCentral 238 Gears Up for Fall 2021 Opening to Meet Biotech Startup Demand for Biomanufacturing
August 04, 2021 -
Alumni Company Q&A: Catamaran Bio
July 27, 2021 -
LabCentral Announces Pfizer “Golden Ticket” Winners Octagon Therapeutics and Thymmune Therapeutics
July 22, 2021 -
Leave No (Higher Ed) Stone Unturned: Building Equitable Internship Programs
June 10, 2021 -
Tidal Therapeutics: the benefits and leverage of the LabCentral model
June 03, 2021 -
LabCentral Appoints Dr. Jo Viney to its Board of Directors
May 07, 2021 -
LabCentral Releases 2020 Impact Report: Companies Raised $3.7 Billion in Funding and 33% of 2020 Massachusetts Bio-Pharma IPOs Started in the LabCentral Network
April 09, 2021 -
ONO Entered Sponsorship Agreements with LabCentral and MBC BioLabs
February 25, 2021 -
LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation
February 18, 2021